← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Zenobia Therapeutics, Inc
San Diego, CA
$1,182,878
Total funding
3
Grants
Funding over time
peak $456.3K · FY2009–17$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,182,878 · 3
By mechanism
R43$1,182,878 · 3
Investigators at Zenobia Therapeutics, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Discovery of inhibitors of the lipopolysaccharide synthesis pathway enzymes LpxA$456,299
R43 · FY2010 · AI
HOT-ROXS: An integrated platform for identifying activators of "non-druggable" targets using biophysical screening, x-ray solution scattering and high-throughput co-crystallization$347,750
R43 · FY2016 · TR
Discovery of inhibitors of ALK for the treatment of cancer$328,829
R43 · FY2009 · CA
I-Corp Program fro HOT-ROXS: An integrated platform for identifying activators of "non-druggable" targets$50,000
R43 · FY2017 · TR